The natural history of Becker muscular dystrophy: A systematic literature review
This SLR highlights the variability in disease presentation in BMD. Stratifying BMD populations into phenotype groups based on the full spectrum of clinical manifestations may better capture disease progression and enhance comparability across studies.Included clinical trials:ClinicalTrials.gov NCT01070511 (https://clinicaltrials.gov/study/NCT01070511), ClinicalTrials.gov NCT02147639 (https://clinicaltrials.gov/study/NCT02147639?term=Becker%20Muscular%20Dystrophy&intr=Sodium%20Nitrate&rank=3), ClinicalTrials.gov NCT01350154 and EudraCT number: 2010-024659-10 (https://clinicaltrials.gov/study/NCT01350154?term=NCT01350154&rank=1; https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024659-10/results).
Authors
- Karissa Johnston (ORCID: https://orcid.org/0000-0003-4570-9972)
- A. Mickle (ORCID: https://orcid.org/0009-0004-2884-1167)
- Kristen Ricchetti-Masterson (ORCID: https://orcid.org/0000-0001-6970-7045)
- Katherine Gooch (ORCID: https://orcid.org/0009-0000-6382-614X)
- SARAH G.C. KORPACH
- Andrew R Kennedy
Institutions
- Sarepta Therapeutics (United States) (US)
Publication Details
- Journal
- Journal of Neuromuscular Diseases
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1177/22143602261420045
- Primary Topic
- Muscle Physiology and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00